{"id":"W3166578944","doi":"10.1200/jco.2021.39.15_suppl.9506","title":"CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Placebo; Oncology; Immunotherapy; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001147238,0.000103504,0.001172144,0.00007890526,0.00001560873,0.000005398013,0.0000903277,0.0002079979,0.0002510404],"category_scores_gemma":[0.001104745,0.00006412593,0.0003132863,0.0001659445,0.0001066758,0.00008553937,0.00002542824,0.0005807907,0.00001109234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001571743,"about_ca_system_score_gemma":0.001205237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007264855,"about_ca_topic_score_gemma":0.00007675297,"domain_scores_codex":[0.9975966,0.0002045625,0.00158307,0.0001437454,0.0002921686,0.0001798293],"domain_scores_gemma":[0.9978923,0.0005487846,0.0008769234,0.0001631148,0.0003609235,0.0001580143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01801915,0.001953028,0.848212,0.00001512415,0.0003588721,0.0005932061,0.00005004141,0.000002962822,0.0001471191,0.00001377679,0.0005394078,0.1300953],"study_design_scores_gemma":[0.03319666,0.01170645,0.9082076,0.0001151742,0.00009404073,0.000066176,0.0001230654,0.0000023225,0.00021819,0.00003682356,0.04616157,0.00007194],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905738,0.0002909595,0.00001170164,0.005244211,0.0008788786,0.0001068884,0.0000021649,0.000004762792,0.002886617],"genre_scores_gemma":[0.9922613,0.0006231242,0.00284232,0.00347924,0.0001844127,0.000001880639,0.000003114369,0.00001376815,0.0005908668],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1300234,"threshold_uncertainty_score":0.2748716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05612230571088557,"score_gpt":0.4330547917870903,"score_spread":0.3769324860762048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}